Turn Therapeutics Inc. (TTRX)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

12.00 on 9 Oct 2026

9 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$3.19M

Free cash flow

$2.56M

Return on equity

-68.2%

Return on capital

-43.1%

Debt to equity

1.29

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
12 Dec 2025	Chaudhary Zuraiz See Remarks	Bought	$8.75K	25.0%
24 Nov 2025	GOLDEN ARTHUR F Director	Bought	$33.95K	19.5%
21 Nov 2025	GOLDEN ARTHUR F Director	Bought	$58.93K	68.0%
21 Nov 2025	Chaudhary Zuraiz See Remarks	Bought	$3.29K	11.1%
20 Nov 2025	Chaudhary Zuraiz See Remarks	Bought	$3.78K	19.2%
17 Nov 2025	Chaudhary Zuraiz See Remarks	Bought	$9.05K	49.5%

42out of 100

Profitability 0

Financial strength 45

Growth n/a

Insiders 100

Strongest on insiders (100), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$308.46K

9 buys, 3 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan